EMBL-EBI adiponectin levels, body mass index, hdl cholesterol, heel bone mineral density, medication use (calcium channel blockers), medication use (hmg coa reductase inhibitors), reticulocyte count, triglyceride levels, triglycerides, waist circumference adjusted for bmi (adjusted for smoking behaviour), waist circumference adjusted for bmi (joint analysis main effects and physical activity interaction), waist circumference adjusted for bmi (joint analysis main effects and smoking interaction), waist circumference adjusted for bmi in active individuals, waist circumference adjusted for bmi in inactive individuals, waist circumference adjusted for bmi in non-smokers, waist circumference adjusted for body mass index, waist-hip ratio, waist-to-hip ratio adjusted for bmi, waist-to-hip ratio adjusted for bmi (age <50), waist-to-hip ratio adjusted for bmi (age >50), waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction), waist-to-hip ratio adjusted for bmi in active individuals, waist-to-hip ratio adjusted for bmi x sex interaction, waist-to-hip ratio adjusted for bmi x sex x age interaction (4df test), waist-to-hip ratio adjusted for body mass index, white blood cell count
GRASP 2 hour glucose, adiponectin levels, body mass index (bmi), coronary artery disease (cad), diastolic blood pressure (dbp), hdl cholesterol, height, ldl cholesterol change with statins, rheumatoid arthritis, serum creatinine, simpson-angus scale, systolic blood pressure (sbp), triglycerides, triglycerides (females), triglycerides (males), waist hip ratio